Health and population

Health and population dynamics are intertwined, embodying an intricate relationship with significant implications on the Sustainable Development Goals (SDGs). Health is fundamentally at the center of these 17 global goals, aimed to transform the world by 2030. Specifically, Goal 3 endeavors to "Ensure healthy lives and promote well-being for all at all ages." It acknowledges that health is pivotal to human life quality, social cohesion, and sustainable development. Inextricably linked to this are the complexities of population dynamics, including growth rates, age structure, fertility and mortality rates, and migration patterns.

With the world's population projected to exceed 9.7 billion by 2050, the pressure on health systems will undoubtedly escalate. The demographic transition, with an aging population and an increasing prevalence of non-communicable diseases, poses new challenges for health systems globally. Additionally, areas with high fertility rates often overlap with extreme poverty, resulting in heightened health risks, including higher maternal and child mortality rates, malnutrition, and infectious diseases.

Moreover, rapid urbanization and migration present both opportunities and threats to health. While urban areas may provide better access to healthcare, they also harbor risks of disease transmission, air and water pollution, and social determinants of health like inadequate housing and social inequality. Simultaneously, migrants often face disproportionate health risks due to unstable living conditions, exploitation, and limited access to healthcare services.

Achieving the SDGs will necessitate comprehensive approaches that consider the intricate interplay of health and population dynamics. It means strengthening health systems, promoting universal health coverage, and addressing social determinants of health. It also implies crafting policies that recognize demographic realities and foster an environment conducive to sustainable development. Only by understanding and harnessing these dynamics can the world meaningfully progress towards realizing the SDGs, ensuring healthy lives and well-being for all.

This Personal View supprts SDGs 3 and 10 by discussing the multifaceted approach and the various stakeholder involvement needed for the expansion of access to new antibiotics while balancing with the prevention of excessive use
This Series paper supports SDG 3 by providing an overview of the current state of health insurance in some African and Asian countries, focusing on how coverage varies across and within countries, and the association between insurance status and use of key preventive health-care services and health system competence.
Elsevier,

Atlas of Common Pain Syndromes, Fifth Edition, 2024, Pages 524-528

This content aligns with Goal 3: Good Health by addressing the complex phenomenon of phantom limb pain, which can significantly affect the quality of life for individuals who have undergone amputations. By understanding the mechanisms behind this condition and the varied experiences of patients, healthcare providers can develop more effective pain management strategies and psychological support systems, ultimately improving patient outcomes. Additionally, it supports Goal 10: Reduced Inequalities by highlighting the need for tailored medical interventions that recognize the unique challenges faced by amputees, ensuring that all patients, regardless of their background or circumstances, receive comprehensive care that addresses both physical and emotional aspects of their recovery.

This content aligns with Goal 3: Good Health by providing a comprehensive overview of impulsivity in individuals with attention deficit hyperactivity disorder (ADHD), emphasizing the need for effective management strategies that include psychoeducation, pharmacological treatments, and psychosocial interventions to improve health outcomes. By highlighting the multifaceted nature of impulsivity and its evolving symptoms across different life stages, the content underscores the importance of tailored treatment approaches that address the unique needs of individuals with ADHD. Additionally, it supports Goal 10: Reduced Inequalities by recognizing the varied presentations of ADHD, especially in women, and advocating for accessible and appropriate interventions that ensure all individuals, regardless of their gender or background, receive the necessary support to manage their condition and enhance their quality of life.
Elsevier, International Review of Neurobiology, Volume 177, January 2024
Alzheimer's disease (AD) stands as the most prevalent form of neuropsychiatric disorder among the elderly population, impacting a minimum of 50 million individuals worldwide. Current pharmacological treatments rely on the prescribing cholinesterase inhibitors and memantine.
Alzheimer's disease (AD) presents a growing global challenge, with an increasing prevalence and significant impact on individuals and public health.
Elsevier, Progress in Brain Research, Volume 289, January 2024
Coffee, a universally consumed beverage, is known to contain thousands of bioactive constituents that have garnered interest due to their potential neuroprotective effects against various neurodegenerative disorders, including Alzheimer's disease (AD).
Dementia is a progressive neurological and degenerative syndrome that affects an individuals' memory, thinking, and social abilities severely enough to interfere with their daily lives. It is emerging as a public health priority in terms of the associated disability and mortality.
Elsevier, Microbial Biofilms: Role in Human Infectious Diseases, Volume , 1 January 2024
Humans harbor complex communities of microbes, predominantly bacteria, that live symbiotically within the colon. There are several factors that influence the trajectory of gut microbiota in infants such as birth term, mode of delivery, and dietary habits.
Elsevier, A Review on Diverse Neurological Disorders: Pathophysiology, Molecular Mechanisms, and Therapeutics, Volume , 1 January 2024
Due to the aging population, both Alzheimer's disease (AD) and Parkinson's disease (PD) are degenerative brain disorders that are now recognized as important public health issues.

Pages